Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Centocor ( CNTO ) -- Ignore unavailable to you. Want to Upgrade?

To: silInv who wrote (920)	5/3/1999 9:34:00 AM
From: Biomaven	Read Replies (1) \| Respond to of 965

More takeover speculation in Bloomberg today: Centocor Inc. (CNTO): Johnson & Johnson (JNJ) is close to an agreement to acquire the biotechnology company, a person familiar with the discussions said. Centocor's shares rose 27 percent since April 20 on the takeover speculation. Both companies have declined comment. Centocor shares rose 9/16 to 44 3/8. J&J shares fell 1 3/16 to 97 1/2. It certainly (like AGPH) fits the takeover profile - it's not dilutive and it's still pretty cheap. I'm currently modestly long. There's still a big short position (5.5 million, but it's down a lot from 6 months ago.) Peter